Clinical Research Directory
Browse clinical research sites, groups, and studies.
Amniotic Fluid Mesenchymal Stem Cells Developed for Chondrogenic Treatment (AFCC) Injection in Elderly Knee Osteoarthritis Patients
Sponsor: Siriraj Hospital
Summary
Amniotic fluid mesenchymal stem cells developed for chondrogenic treatment (AFCC) are used to treat elderly patients suffering from knee osteoarthritis (OA). The injection reduces inflammation and promotes the recovery of knee function, leading to an improved quality of life.
Official title: A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients
Key Details
Gender
All
Age Range
60 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-08-17
Completion Date
2025-03
Last Updated
2024-04-26
Healthy Volunteers
No
Conditions
Interventions
allogenic amniotic fluid mesenchymal stem cell
Intra-articular AFCC injection will be given for single knee for each patient in single dose, 20 million of AFCC in each dose
Locations (1)
Siriraj Hospital
Bangkok Noi, Bangkok, Thailand